The recovery of European air connectivity from the COVID-19 pandemic is uneven and still difficult, according to the Airport Industry Connectivity Report for 2022. This reflects the combination of yet not fully
Nicosia backs Ukraine’s application to enter the European Union, which is on the agenda of EU leaders in Brussels on Thursday. Ukraine is set to be approved as an EU candidate at
Cypriots cannot agree on whether EU sanctions on Russia imposed for its invasion of Ukraine are justified, as nearly half don’t support the bloc’s decisions. Only 54% of Cypriots said they were
Draft conclusions of the upcoming European Council contain concerns expressed by the EU over Turkey’s tension-raising behaviour in the Aegean and East Med. These concerns were brought before Tuesday’s General Affairs Council
A first visit to the island by royal couple Prince Edward and Sophie underscores the evolving and improved relations between Britain and its former colony Cyprus, President Nicos Anastasiades said Tuesday. During
The European Medicines Agency (EMA) has started a rolling review for a Spikevax (Moderna) vaccine adapted to provide better protection against specific variants of SARS-CoV-2. The Ministry of Health said the review
Interior Minister Nicos Nouris and the International Organisation for Migration’s Regional Director, Ola Henrikson, discussed ways to enhance and increase financial cooperation between the two parties to return irregular migrants. During his first
Breakaway Turkish Cypriots are responsible for stemming migrant arrivals, a senior European Union official said, as the number of asylum-seekers the Republic receives soars. European Commission Vice President Margaritis Schinas said that
Greek Prime Minister Kyriakos Mitsotakis said Friday he preferred diplomacy over ratchet rhetoric with Turkey over disagreements in the Aegean Sea, where the two are at loggerheads over territory and airspace. Mitsotakis
The European Medicines Agency (EMA) has started a rolling review for a version of Comirnaty adapted to provide better protection against a specific variant or variants of SARS-CoV-2, the virus that causes COVID-19.
